BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ferro D, Quintarelli C, Lattuada A, Leo R, Alessandroni M, Mannucci PM, Violi F. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: relationship to endotoxemia. Hepatology. 1996;23:1377-1383. [PMID: 8675154 DOI: 10.1002/hep.510230613] [Cited by in Crossref: 108] [Cited by in F6Publishing: 92] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Saliola M, Lorenzet R, Ferro D, Basili S, Caroselli C, Santo AD, Sallese M, Violi F. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut 1998;43:428-32. [PMID: 9863491 DOI: 10.1136/gut.43.3.428] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 1.7] [Reference Citation Analysis]
2 Bode C, Bode JC. Effect of alcohol consumption on the gut. Best Pract Res Clin Gastroenterol. 2003;17:575-592. [PMID: 12828956 DOI: 10.1016/s1521-6918(03)00034-9] [Cited by in Crossref: 216] [Cited by in F6Publishing: 86] [Article Influence: 12.0] [Reference Citation Analysis]
3 Wang L, Zhao X, Feng Y, Ma X, Wu H, Zhu Q. Intrahepatic angiogenesis increases portal hypertension in hepatitis B patients with cirrhosis. Hepatol Res 2017;47:E94-E103. [PMID: 27115574 DOI: 10.1111/hepr.12732] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
4 Senzolo M, Burra P, Cholongitas E, Burroughs AK. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol 2006;12:7725-36. [PMID: 17203512 DOI: 10.3748/wjg.v12.i48.7725] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 80] [Article Influence: 7.8] [Reference Citation Analysis]
5 Homoncik M, Ferlitsch A, Ferenci P, Formann E, Jilma B, Gangl A, Panzer S, Peck-Radosavljevic M. Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C. Aliment Pharmacol Ther 2005;21:49-55. [PMID: 15644045 DOI: 10.1111/j.1365-2036.2004.02305.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ko S, Chisuwa H, Matsumoto M, Fujimura Y, Okano E, Nakajima Y. Relevance of ADAMTS13 to liver transplantation and surgery. World J Hepatol 2015;7:1772-81. [PMID: 26167250 DOI: 10.4254/wjh.v7.i13.1772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
7 Ferro D, Angelico F, Caldwell SH, Violi F. Bleeding and thrombosis in cirrhotic patients: what really matters? Dig Liver Dis. 2012;44:275-279. [PMID: 22119620 DOI: 10.1016/j.dld.2011.10.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
8 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Determination of ADAMTS13 and Its Clinical Significance for ADAMTS13 Supplementation Therapy to Improve the Survival of Patients with Decompensated Liver Cirrhosis. Int J Hepatol 2011;2011:759047. [PMID: 21994870 DOI: 10.4061/2011/759047] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
9 Mandorfer M, Schwabl P, Paternostro R, Pomej K, Bauer D, Thaler J, Ay C, Quehenberger P, Fritzer-Szekeres M, Peck-Radosavljevic M, Trauner M, Reiberger T, Ferlitsch A; Vienna Hepatic Hemodynamic Lab. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity. Aliment Pharmacol Ther 2018;47:980-8. [PMID: 29377193 DOI: 10.1111/apt.14522] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 11.3] [Reference Citation Analysis]
10 Horvatits T, Drolz A, Roedl K, Herkner H, Ferlitsch A, Perkmann T, Müller C, Trauner M, Schenk P, Fuhrmann V. Von Willebrand factor antigen for detection of hepatopulmonary syndrome in patients with cirrhosis. J Hepatol. 2014;61:544-549. [PMID: 24798623 DOI: 10.1016/j.jhep.2014.04.025] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
11 He B, Zhang H, Shi T. A comprehensive analysis of the dynamic biological networks in HCV induced hepatocarcinogenesis. PLoS One 2011;6:e18516. [PMID: 21526182 DOI: 10.1371/journal.pone.0018516] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
12 Lisman T, Violi F. Cirrhosis as a risk factor for venous thrombosis. Thromb Haemost 2017;117:03-5. [DOI: 10.1160/th16-10-0782] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
13 Northup PG. Hypercoagulation in liver disease. Clin Liver Dis. 2009;13:109-116. [PMID: 19150315 DOI: 10.1016/j.cld.2008.09.003] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
14 Wu H, Yan S, Wang G, Cui S, Zhang C, Zhu Q. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis. Scand J Gastroenterol. 2015;50:1160-1169. [PMID: 25877661 DOI: 10.3109/00365521.2015.1037346] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
15 Reuken PA, Kussmann A, Kiehntopf M, Budde U, Stallmach A, Claus RA, Bruns T. Imbalance of von Willebrand factor and its cleaving protease ADAMTS13 during systemic inflammation superimposed on advanced cirrhosis. Liver Int 2015;35:37-45. [PMID: 25113276 DOI: 10.1111/liv.12657] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
16 Arshad F, Ickx B, van Beem RT, Polak W, Grüne F, Nevens F, Ilmakunnas M, Koivusalo AM, Isoniemi H, Strengers PF. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial. BMC Surg. 2013;13:22. [PMID: 23815798 DOI: 10.1186/1471-2482-13-22] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 6.3] [Reference Citation Analysis]
17 Maieron A, Salzl P, Peck-Radosavljevic M, Trauner M, Hametner S, Schöfl R, Ferenci P, Ferlitsch M. Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. Aliment Pharmacol Ther. 2014;39:331-338. [PMID: 24308724 DOI: 10.1111/apt.12564] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
18 Wannhoff A, Rauber C, Friedrich K, Rupp C, Stremmel W, Weiss KH, Schemmer P, Gotthardt DN. Von Willebrand factor and alkaline phosphatase predict re-transplantation-free survival after the first liver transplantation. United European Gastroenterol J 2017;5:86-93. [PMID: 28405326 DOI: 10.1177/2050640616650060] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
19 Hametner S, Ferlitsch A, Ferlitsch M, Etschmaier A, Schöfl R, Ziachehabi A, Maieron A. The VITRO Score (Von Willebrand Factor Antigen/Thrombocyte Ratio) as a New Marker for Clinically Significant Portal Hypertension in Comparison to Other Non-Invasive Parameters of Fibrosis Including ELF Test. PLoS One. 2016;11:e0149230. [PMID: 26895398 DOI: 10.1371/journal.pone.0149230] [Cited by in Crossref: 34] [Cited by in F6Publishing: 21] [Article Influence: 6.8] [Reference Citation Analysis]
20 Györi GP, Pereyra D, Rumpf B, Hackl H, Köditz C, Ortmayr G, Reiberger T, Trauner M, Berlakovich GA, Starlinger P. The von Willebrand Factor Facilitates Model for End-Stage Liver Disease-Independent Risk Stratification on the Waiting List for Liver Transplantation. Hepatology 2020;72:584-94. [PMID: 31773739 DOI: 10.1002/hep.31047] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Semmler G, Binter T, Kozbial K, Schwabl P, Hametner-Schreil S, Zanetto A, Gavasso S, Chromy D, Bauer DJM, Simbrunner B, Scheiner B, Bucsics T, Stättermayer AF, Pinter M, Steindl-Munda P, Schöfl R, Russo FP, Simioni P, Trauner M, Ferenci P, Reiberger T, Mandorfer M. Noninvasive Risk Stratification After HCV Eradication in Patients With Advanced Chronic Liver Disease. Hepatology 2021;73:1275-89. [PMID: 32659847 DOI: 10.1002/hep.31462] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
22 Ferlitsch M, Reiberger T, Hoke M, Salzl P, Schwengerer B, Ulbrich G, Payer BA, Trauner M, Peck-Radosavljevic M, Ferlitsch A. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis. Hepatology. 2012;56:1439-1447. [PMID: 22532296 DOI: 10.1002/hep.25806] [Cited by in Crossref: 108] [Cited by in F6Publishing: 89] [Article Influence: 12.0] [Reference Citation Analysis]
23 Zanetto A, Senzolo M, Ferrarese A, Simioni P, Burra P, Rodríguez-castro KI. Assessment of Bleeding Risk in Patients with Cirrhosis. Curr Hepatology Rep 2015;14:9-18. [DOI: 10.1007/s11901-015-0250-1] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Groeneveld D, Cline-Fedewa H, Baker KS, Williams KJ, Roth RA, Mittermeier K, Lisman T, Palumbo JS, Luyendyk JP. Von Willebrand factor delays liver repair after acetaminophen-induced acute liver injury in mice. J Hepatol 2020;72:146-55. [PMID: 31606553 DOI: 10.1016/j.jhep.2019.09.030] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
25 Lisman T, Leebeek FW. Hemostatic alterations in liver disease: a review on pathophysiology, clinical consequences, and treatment. Dig Surg. 2007;24:250-258. [PMID: 17657149 DOI: 10.1159/000103655] [Cited by in Crossref: 119] [Cited by in F6Publishing: 88] [Article Influence: 8.5] [Reference Citation Analysis]
26 Andriulli A, Tripodi A, Angeli P, Senzolo M, Primignani M, Giannini EG, Riggio O, Colli A, Prati D, Sacerdoti D, Merkel C, Basili S, Ferro D, Villa E, Di Minno G, Caraceni P, Marzioni M, Mannucci PM, Violi F, Piscaglia F, Calvaruso V, De Pietri L, Falcone M, Feltracco P, Grandone E, La Mura V, Licata A, Lucidi C, Maimone S, Marietta M, Morisco F, Napoleone L, Piano S, Raparelli V, Rebulla P, Ribero D, Sartori MT, Scalera A, Schepis F, Siciliano M, Baroni GS, Tufano A, Vitale A, Zuin M. Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference. Digestive and Liver Disease 2016;48:455-67. [DOI: 10.1016/j.dld.2016.02.008] [Cited by in Crossref: 31] [Cited by in F6Publishing: 21] [Article Influence: 6.2] [Reference Citation Analysis]
27 Yilmaz VT, Dincer D, Avci AB, Cetinkaya R. Significant Association between Serum Levels of Von Willebrand Factor (vWF) Antigen with Stages of Cirrhosis. Eurasian J Med 2015;47:21-5. [PMID: 25745341 DOI: 10.5152/eajm.2014.0016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
28 Magnusson M, Ignjatovic V, Hardikar W, Monagle P. A conceptual and practical approach to haemostasis in paediatric liver disease. Arch Dis Child. 2016;101:854-859. [PMID: 27013527 DOI: 10.1136/archdischild-2015-309535] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
29 Amer A, Amer ME. Enhanced monocyte tissue factor expression in hepatosplenic Schistosomiasis: . Blood Coagulation & Fibrinolysis 2002;13:43-7. [DOI: 10.1097/00001721-200201000-00006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
30 Cruz-Ramón V, Chinchilla-López P, Ramírez-Pérez O, Méndez-Sánchez N. Effects of Portal Vein Thrombosis on the Outcomes of Liver Cirrhosis: A Mexican Perspective. J Transl Int Med 2017;5:189-91. [PMID: 29340273 DOI: 10.1515/jtim-2017-0031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
31 Ahmed Hassan E, Sharaf El-Din Abd El-Rehim A, Ahmed Sayed ZE, Farah Mohamed Kholef E, Sabry A, Abd El-Rehim Abo Elhagag N. VAP score as a novel non-invasive liver fibrosis model in patients with chronic hepatitis C. Hepatol Res 2017;47:1408-16. [PMID: 28247581 DOI: 10.1111/hepr.12884] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
32 Cai J, Tian J, Chen K, Cheng L, Xuan M, Cheng B. Erbium fractional laser irradiation combined with autologous platelet‐rich plasma and platelet‐poor plasma application for facial rejuvenation. J Cosmet Dermatol 2020;19:1975-9. [DOI: 10.1111/jocd.13241] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Giannini EG, Stravitz RT, Caldwell SH. Portal vein thrombosis and chronic liver disease progression: The closer you look the more you see: HEPATOLOGY, Vol. XX, No. X, 2015. Hepatology 2016;63:342-3. [DOI: 10.1002/hep.27875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
34 de Toledo CF, Carvente CT, Shigueoka DC, Borges DR. Endothelial markers in schistosomiasis patients with or without portal hypertension. Dig Dis Sci 2009;54:1331-6. [PMID: 18754093 DOI: 10.1007/s10620-008-0475-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
35 Lisman T, Bongers TN, Adelmeijer J, Janssen HL, de Maat MP, de Groot PG, Leebeek FW. Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity. Hepatology. 2006;44:53-61. [PMID: 16799972 DOI: 10.1002/hep.21231] [Cited by in Crossref: 355] [Cited by in F6Publishing: 262] [Article Influence: 23.7] [Reference Citation Analysis]
36 Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol. 2015;7:425-442. [PMID: 25848468 DOI: 10.4254/wjh.v7.i3.425] [Cited by in Crossref: 94] [Cited by in F6Publishing: 83] [Article Influence: 15.7] [Reference Citation Analysis]
37 Ferro D, Pittoni V, Quintarelli C, Basili S, Saliola M, Caroselli C, Valesini G, Violi F. Coexistence of Anti-Phospholipid Antibodies and Endothelial Perturbation in Systemic Lupus Erythematosus Patients With Ongoing Prothrombotic State. Circulation 1997;95:1425-32. [DOI: 10.1161/01.cir.95.6.1425] [Cited by in Crossref: 45] [Cited by in F6Publishing: 6] [Article Influence: 1.9] [Reference Citation Analysis]
38 Al-ruzzeh S, Navia JL. The “Off-Label” Role of Recombinant Factor VIIa in Surgery: Is the Problem Deficient Evidence or Defective Concept? Journal of the American College of Surgeons 2009;209:659-67. [DOI: 10.1016/j.jamcollsurg.2009.07.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
39 Kalambokis GN, Baltayiannis G, Christodoulou D. von Willebrand factor antigen as a therapeutic target of portal hypertension in cirrhosis. World J Gastroenterol 2016;22:4786-8. [PMID: 27217711 DOI: 10.3748/wjg.v22.i19.4786] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
40 Ohuchi H, Hayama Y, Miike H, Suzuki D, Nakajima K, Iwasa T, Konagai N, Sakaguchi H, Miyazaki A, Shiraishi I, Kurosaki KI, Nakai M. Prognostic value of von Willebrand factor in adult patients with congenital heart disease. Heart 2020;106:910-5. [PMID: 32188625 DOI: 10.1136/heartjnl-2019-316007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
41 Uemura M, Fujimura Y, Ko S, Matsumoto M, Nakajima Y, Fukui H. Pivotal role of ADAMTS13 function in liver diseases. Int J Hematol. 2010;91:20-29. [PMID: 20054668 DOI: 10.1007/s12185-009-0481-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
42 Miele L, Alberelli MA, Martini M, Liguori A, Marrone G, Cocomazzi A, Vecchio FM, Landolfi R, Gasbarrini A, Grieco A, De Candia E. Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets. Transl Res 2021;231:24-38. [PMID: 33171266 DOI: 10.1016/j.trsl.2020.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Smalberg JH, Leebeek FWG. Superimposed coagulopathic conditions in cirrhosis: infection and endogenous heparinoids, renal failure, and endothelial dysfunction. Clin Liver Dis 2009;13:33-42. [PMID: 19150307 DOI: 10.1016/j.cld.2008.09.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
44 Hugenholtz GC, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT, Lisman T. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology. 2013;58:752-761. [PMID: 23468040 DOI: 10.1002/hep.26372] [Cited by in Crossref: 99] [Cited by in F6Publishing: 73] [Article Influence: 12.4] [Reference Citation Analysis]
45 Raparelli V, Basili S, Carnevale R, Napoleone L, Del Ben M, Nocella C, Bartimoccia S, Lucidi C, Talerico G, Riggio O, Violi F. Low-grade endotoxemia and platelet activation in cirrhosis. Hepatology 2017;65:571-81. [PMID: 27641757 DOI: 10.1002/hep.28853] [Cited by in Crossref: 60] [Cited by in F6Publishing: 57] [Article Influence: 12.0] [Reference Citation Analysis]
46 Arshad F, Stoof SC, Leebeek FW, Ruitenbeek K, Adelmeijer J, Blokzijl H, van den Berg AP, Porte RJ, Kruip MJ, Lisman T. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis. Liver Int. 2015;35:1809-1815. [PMID: 25522671 DOI: 10.1111/liv.12765] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
47 Fernández J, Monteagudo J, Bargallo X, Jiménez W, Bosch J, Arroyo V, Navasa M. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology. 2005;42:627-634. [PMID: 16108036 DOI: 10.1002/hep.20829] [Cited by in Crossref: 152] [Cited by in F6Publishing: 111] [Article Influence: 9.5] [Reference Citation Analysis]
48 Kukla M, Waluga M, Żorniak M, Berdowska A, Wosiewicz P, Sawczyn T, Bułdak RJ, Ochman M, Ziora K, Krzemiński T, Hartleb M. Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol 2017;23:2613-24. [PMID: 28465646 DOI: 10.3748/wjg.v23.i14.2613] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
49 Takaya H, Uemura M, Fujimura Y, Matsumoto M, Matsuyama T, Kato S, Morioka C, Ishizashi H, Hori Y, Fujimoto M, Tsujimoto T, Kawaratani H, Toyohara M, Kurumatani N, Fukui H. ADAMTS13 activity may predict the cumulative survival of patients with liver cirrhosis in comparison with the Child-Turcotte-Pugh score and the Model for End-Stage Liver Disease score. Hepatol Res 2012;42:459-72. [PMID: 22292786 DOI: 10.1111/j.1872-034X.2011.00950.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
50 Barton CA. Treatment of Coagulopathy Related to Hepatic Insufficiency: . Critical Care Medicine 2016;44:1927-33. [DOI: 10.1097/ccm.0000000000001998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
51 Joshi N, Kopec AK, Ray JL, Cline-Fedewa H, Groeneveld DJ, Lisman T, Luyendyk JP. Von Willebrand factor deficiency reduces liver fibrosis in mice. Toxicol Appl Pharmacol 2017;328:54-9. [PMID: 28527913 DOI: 10.1016/j.taap.2017.05.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
52 Baruch Y, Neubauer K, Shenkar L, Sabo E, Ritzel A, Wilfling T, Ramadori G. Von Willebrand factor in plasma and in liver tissue after partial hepatectomy in the rat. Journal of Hepatology 2002;37:471-7. [DOI: 10.1016/s0168-8278(02)00215-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
53 Albillos A, de la Hera A, González M, Moya JL, Calleja JL, Monserrat J, Ruiz-del-Arbol L, Alvarez-Mon M. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003;37:208-217. [PMID: 12500206 DOI: 10.1053/jhep.2003.50038] [Cited by in Crossref: 295] [Cited by in F6Publishing: 271] [Article Influence: 16.4] [Reference Citation Analysis]
54 Violi F, Basili S, Raparelli V, Chowdary P, Gatt A, Burroughs AK. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction? J Hepatol 2011;55:1415-27. [PMID: 21718668 DOI: 10.1016/j.jhep.2011.06.008] [Cited by in Crossref: 107] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
55 Hasan RA, Koh AY, Zia A. The gut microbiome and thromboembolism. Thromb Res 2020;189:77-87. [PMID: 32192995 DOI: 10.1016/j.thromres.2020.03.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
56 Ding XC, Ma WL, Li MK, Liu SW, Liu XY, Hai L, Luo X, Hu YC, Ma LN. A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension. J Clin Transl Hepatol 2019;7:3-8. [PMID: 30944812 DOI: 10.14218/JCTH.2018.00036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Stine JG, Northup PG. Coagulopathy Before and After Liver Transplantation: From the Hepatic to the Systemic Circulatory Systems. Clin Liver Dis 2017;21:253-74. [PMID: 28364812 DOI: 10.1016/j.cld.2016.12.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
58 Blasi A. Coagulopathy in liver disease: Lack of an assessment tool. World J Gastroenterol 2015;21:10062-71. [PMID: 26401071 DOI: 10.3748/wjg.v21.i35.10062] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 15] [Article Influence: 4.2] [Reference Citation Analysis]
59 Tsuchiya S, Matsumoto Y, Doman T, Fujiya T, Sugisawa J, Suda A, Sato K, Ikeda S, Shindo T, Kikuchi Y, Hao K, Takahashi J, Hatta W, Koike T, Masamune A, Saiki Y, Horiuchi H, Shimokawa H. Disappearance of Angiodysplasia Following Transcatheter Aortic Valve Implantation in a Patient with Heyde's Syndrome: A Case Report and Review of the Literature. J Atheroscler Thromb 2020;27:271-7. [PMID: 31378751 DOI: 10.5551/jat.49239] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
60 Kalambokis GN, Oikonomou A, Christou L, Kolaitis NI, Tsianos EV, Christodoulou D, Baltayiannis G. von Willebrand factor and procoagulant imbalance predict outcome in patients with cirrhosis and thrombocytopenia. J Hepatol 2016;65:921-8. [PMID: 27297911 DOI: 10.1016/j.jhep.2016.06.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
61 Garcia-Martinez R, Andreola F, Mehta G, Poulton K, Oria M, Jover M, Soeda J, Macnaughtan J, De Chiara F, Habtesion A, Mookerjee RP, Davies N, Jalan R. Immunomodulatory and antioxidant function of albumin stabilises the endothelium and improves survival in a rodent model of chronic liver failure. J Hepatol. 2015;62:799-806. [PMID: 25450713 DOI: 10.1016/j.jhep.2014.10.031] [Cited by in Crossref: 47] [Cited by in F6Publishing: 35] [Article Influence: 6.7] [Reference Citation Analysis]
62 Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem. 2007;282:26294-26305. [PMID: 17569671 DOI: 10.1074/jbc.m609711200] [Cited by in Crossref: 157] [Cited by in F6Publishing: 76] [Article Influence: 11.2] [Reference Citation Analysis]
63 Roberts LN, Patel RK, Arya R. Haemostasis and thrombosis in liver disease. British Journal of Haematology 2010;148:507-21. [DOI: 10.1111/j.1365-2141.2009.08021.x] [Cited by in Crossref: 71] [Cited by in F6Publishing: 52] [Article Influence: 6.5] [Reference Citation Analysis]
64 Schwarzer R, Reiberger T, Mandorfer M, Kivaranovic D, Hametner S, Hametner S, Paternostro R, Scheiner B, Schneeweiss-Friedl J, Trauner M, Schoefl R, Maieron A. The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. J Gastroenterol 2020;55:533-42. [PMID: 31832759 DOI: 10.1007/s00535-019-01656-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
65 Hugenholtz GG, Porte RJ, Lisman T. The platelet and platelet function testing in liver disease. Clin Liver Dis. 2009;13:11-20. [PMID: 19150305 DOI: 10.1016/j.cld.2008.09.010] [Cited by in Crossref: 43] [Cited by in F6Publishing: 30] [Article Influence: 3.6] [Reference Citation Analysis]
66 Yang ZJ, Costa KA, Novelli EM, Smith RE. Venous thromboembolism in cirrhosis. Clin Appl Thromb Hemost 2014;20:169-78. [PMID: 23076776 DOI: 10.1177/1076029612461846] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
67 Palyu E, Harsfalvi J, Tornai T, Papp M, Udvardy M, Szekeres-Csiki K, Pataki L, Vanhoorelbeke K, Feys HB, Deckmyn H, Tornai I. Major Changes of von Willebrand Factor Multimer Distribution in Cirrhotic Patients with Stable Disease or Acute Decompensation. Thromb Haemost 2018;118:1397-408. [PMID: 29972862 DOI: 10.1055/s-0038-1661393] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
68 Ferreira CM, Rocha TR, Souza EO, Carrilho FJ, d’Amico EA, Farias AQ. Preservation of thrombin generation in cirrhosis despite abnormal results of international normalized ratio: implications for invasive procedures. Blood Coagulation & Fibrinolysis 2021;32:1-7. [DOI: 10.1097/mbc.0000000000000966] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Ferro D, Basili S, Roccaforte S, Di Franco M, Cipollone F, Ciabattoni G, Dav� G. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis & Rheumatism 1999;42:2689-97. [DOI: 10.1002/1529-0131(199912)42:12<2689::aid-anr27>3.0.co;2-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
70 von Meijenfeldt FA, Lisman T. Fibrinolysis in Patients with Liver Disease. Semin Thromb Hemost 2021;47:601-9. [PMID: 33772480 DOI: 10.1055/s-0040-1718924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Phillips MG, Preedy VR, Hughes RD. Assessment of prognosis in alcoholic liver disease: can serum hyaluronate replace liver biopsy? Eur J Gastroenterol Hepatol 2003;15:941-4. [PMID: 12923364 DOI: 10.1097/00042737-200309000-00001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
72 Jansen VL, Gerdes VE, Middeldorp S, van Mens TE. Gut microbiota and their metabolites in cardiovascular disease. Best Pract Res Clin Endocrinol Metab 2021;35:101492. [PMID: 33642219 DOI: 10.1016/j.beem.2021.101492] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Lancellotti S, Basso M, Veca V, Sacco M, Riccardi L, Pompili M, De Cristofaro R. Presence of portal vein thrombosis in liver cirrhosis is strongly associated with low levels of ADAMTS-13: a pilot study. Intern Emerg Med 2016;11:959-67. [DOI: 10.1007/s11739-016-1467-x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
74 Vieira da Rocha EC, D’Amico EA, Caldwell SH, Flores da Rocha TR, Soares E Silva CS, Dos Santos Bomfim V, Felga G, Barbosa WF, Kassab F, Polli DA. A prospective study of conventional and expanded coagulation indices in predicting ulcer bleeding after variceal band ligation. Clin Gastroenterol Hepatol. 2009;7:988-993. [PMID: 19410018 DOI: 10.1016/j.cgh.2009.04.019] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 4.8] [Reference Citation Analysis]
75 Albornoz L, Alvarez D, Otaso JC, Gadano A, Salviú J, Gerona S, Sorroche P, Villamil A, Mastai R. Von Willebrand factor could be an index of endothelial dysfunction in patients with cirrhosis: relationship to degree of liver failure and nitric oxide levels. J Hepatol. 1999;30:451-455. [PMID: 10190728 DOI: 10.1016/s0168-8278(99)80104-4] [Cited by in Crossref: 51] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
76 Alkim H, Ayaz S, Sasmaz N, Oguz P, Sahin B. Hemostatic Abnormalities in Cirrhosis and Tumor-Related Portal Vein Thrombosis. Clin Appl Thromb Hemost 2012;18:409-15. [DOI: 10.1177/1076029611427900] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
77 Shah NL, Intagliata NM, Northup PG, Argo CK, Caldwell SH. Procoagulant therapeutics in liver disease: a critique and clinical rationale. Nat Rev Gastroenterol Hepatol. 2014;11:675-682. [PMID: 25023035 DOI: 10.1038/nrgastro.2014.121] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 6.6] [Reference Citation Analysis]
78 Bitto N, Liguori E, La Mura V. Coagulation, Microenvironment and Liver Fibrosis. Cells. 2018;7:pii: E85. [PMID: 30042349 DOI: 10.3390/cells7080085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
79 Osada M, Kaneko M, Sakamoto M, Endoh M, Takigawa K, Suzuki-Inoue K, Inoue O, Satoh K, Enomoto N, Yatomi Y, Ozaki Y. Causes of thrombocytopenia in chronic hepatitis C viral infection. Clin Appl Thromb Hemost 2012;18:272-80. [PMID: 22327815 DOI: 10.1177/1076029611429124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
80 Zermatten MG, Fraga M, Moradpour D, Bertaggia Calderara D, Aliotta A, Stirnimann G, De Gottardi A, Alberio L. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis. Hepatology 2020;71:2135-48. [PMID: 32090357 DOI: 10.1002/hep.31201] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
81 Wannhoff A, Müller OJ, Friedrich K, Rupp C, Klöters-Plachky P, Leopold Y, Brune M, Senner M, Weiss KH, Stremmel W, Schemmer P, Katus HA, Gotthardt DN. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis. PLoS One 2014;9:e112583. [PMID: 25397410 DOI: 10.1371/journal.pone.0112583] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
82 Magnusson M, Berndtsson M, Fischler B, Petrini P, Schulman S, Renne T, Granath A, Sten-Linder M, Németh A. Thrombin generation test in children and adolescents with chronic liver disease. Thromb Res. 2015;135:382-387. [PMID: 25541032 DOI: 10.1016/j.thromres.2014.11.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
83 Kim WH, Park JB, Jung CW, Kim GS. Rebalanced hemostasis in patients with idiopathic thrombocytopenic purpura. Platelets 2015;26:38-42. [DOI: 10.3109/09537104.2013.869312] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
84 Wosiewicz P, Żorniak M, Hartleb M, Barański K, Hartleb M, Onyszczuk M, Pilch-Kowalczyk J, Kyrcz-Krzemień S. Portal vein thrombosis in cirrhosis is not associated with intestinal barrier disruption or increased platelet aggregability. Clin Res Hepatol Gastroenterol 2016;40:722-9. [PMID: 27160816 DOI: 10.1016/j.clinre.2016.03.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
85 Di Martino V, Weil D, Cervoni JP, Thevenot T. New prognostic markers in liver cirrhosis. World J Hepatol. 2015;7:1244-1250. [PMID: 26019739 DOI: 10.4254/wjh.v7.i9.1244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
86 Tripodi A, D'ambrosio R, Padovan L, Tosetti G, Aghemo A, Primignani M, Chantarangkul V, Peyvandi F, Colombo M. Evaluation of coagulation during treatment with directly acting antivirals in patients with hepatitis C virus related cirrhosis. Liver Int 2017;37:1295-303. [DOI: 10.1111/liv.13374] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
87 Laffi G, Marra F. Complications of cirrhosis: is endothelium guilty? Journal of Hepatology 1999;30:532-5. [DOI: 10.1016/s0168-8278(99)80117-2] [Cited by in Crossref: 7] [Article Influence: 0.3] [Reference Citation Analysis]
88 Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol. 2002;37:280-287. [PMID: 12127437 DOI: 10.1016/s0168-8278(02)00199-x] [Cited by in Crossref: 159] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
89 Carnevale R, Raparelli V, Nocella C, Bartimoccia S, Novo M, Severino A, De Falco E, Cammisotto V, Pasquale C, Crescioli C, Scavalli AS, Riggio O, Basili S, Violi F. Gut-derived endotoxin stimulates factor VIII secretion from endothelial cells. Implications for hypercoagulability in cirrhosis. J Hepatol. 2017;67:950-956. [PMID: 28716745 DOI: 10.1016/j.jhep.2017.07.002] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
90 Zou Z, Yan X, Li C, Li X, Ma X, Zhang C, Ju S, Tian J, Qi X. von Willebrand factor as a biomarker of clinically significant portal hypertension and severe portal hypertension: a systematic review and meta-analysis. BMJ Open 2019;9:e025656. [PMID: 31473610 DOI: 10.1136/bmjopen-2018-025656] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Northup PG, Caldwell SH. Coagulation in liver disease: a guide for the clinician. Clin Gastroenterol Hepatol. 2013;11:1064-1074. [PMID: 23506859 DOI: 10.1016/j.cgh.2013.02.026] [Cited by in Crossref: 149] [Cited by in F6Publishing: 107] [Article Influence: 18.6] [Reference Citation Analysis]
92 Arroyo V, García-Martinez R, Salvatella X. Human serum albumin, systemic inflammation, and cirrhosis. J Hepatol. 2014;61:396-407. [PMID: 24751830 DOI: 10.1016/j.jhep.2014.04.012] [Cited by in Crossref: 193] [Cited by in F6Publishing: 154] [Article Influence: 27.6] [Reference Citation Analysis]